MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding MAIA Biotechnology, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 19 | 26 | +7 |
| Shares | 2.37M | 2.52M | +143.0K (+6.0%) |
| Value | $3.49M | $4.09M | +$603.9K (+17.3%) |
New holders (9)
Institutions that held MAIA Biotechnology, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 78,757 | $120.5K | 0.00% |
| Creative Planning | 28,822 | $44.1K | 0.00% |
| Ritholtz Wealth Management | 23,071 | $35.3K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,620 | $16.0K | 0.00% |
| StoneX Group Inc. | 10,249 | $15.7K | 0.00% |
| Daytona Street Capital LLC | 7,500 | $11.5K | 0.01% |
| UBS Group AG | 2,170 | $3.32K | 0.00% |
| Rocky Mountain Advisers, LLC | 653 | $999 | 0.00% |
| Tucker Asset Management LLC | 341 | $522 | 0.00% |
Sold out (2)
Institutions that held MAIA Biotechnology, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Marshall Wace, LLP | 110,467 | $170.1K |
| Tower Research Capital LLC (TRC) | 4,026 | $6.20K |